慢性阻塞性肺疾病患者肺功能预测:与定量CT参数的相关性
研究纳入370例COPD患者并按GOLD I-IV分级,采用自动分割软件测量肺气肿指数、空气潴留指数及Pi10等定量CT参数,分析与肺功能指标的相关性并行多元线性回归。结果显示轻中度患者中气道与肺实质衰减参数均为肺功能独立预测因子,重度患者中仅肺实质衰减参数主导。
要点
- COPD患者肺实质衰减参数随GOLD分期升高而显著变差(p < 0.001)。
- Pi10在GOLD III期患者中最高(4.41 ± 0.94 mm)。
- 轻中度COPD中气道与肺实质参数均可预测FEV₁/FVC,重度者仅肺实质衰减参数主导。
核心结论
- 气道参数与肺实质衰减参数是轻度COPD患者肺功能的独立预测因子,而肺实质衰减参数是重度COPD患者肺功能的主要独立预测因子。
研究设计与样本
- 回顾性分析370例COPD患者,按GOLD I-IV标准分组,使用自动分割软件测量定量CT参数,以肺功能检查结果为参考。
关键影像表现/征象
- 肺实质衰减参数在GOLD分期较高的患者中显著更差(p < 0.001)。
- Pi10在GOLD III期患者中最高,为4.41 ± 0.94 mm。
- 气道参数与肺功能结果呈非线性相关。
诊断标准与关键数值
- Pi10与FEV₁/FVC在GOLD II期患者中呈轻度相关(r = 0.16,p = 0.06)。
- Pi10与FEV₁/FVC在GOLD III期患者中呈轻度相关(r = 0.21,p = 0.04)。
- 全样本中肺实质衰减参数、气道参数、EI及Pi10均为FEV₁/FVC的预测因子(R² = 0.38,p < 0.001)。
- Group 1(GOLD I和II)中上述参数均为FEV₁/FVC的预测因子(R² = 0.22,p < 0.001)。
- Group 2(GOLD III和IV)中仅肺实质衰减参数EI为FEV₁/FVC的预测因子(R² = 0.37,p < 0.001)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: We aimed to evaluate correlations between computed tomography (CT) parameters and pulmonary function test (PFT) parameters according to disease severity in patients with chronic obstructive pulmonary disease (COPD), and to determine whether CT parameters can be used to predict PFT indices.
MATERIALS AND METHODS: A total of 370 patients with COPD were grouped based on disease severity according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) I-IV criteria. Emphysema index (EI), air-trapping index, and airway parameters such as the square root of wall area of a hypothetical airway with an internal perimeter of 10 mm (Pi10) were measured using automatic segmentation software. Clinical characteristics including PFT results and quantitative CT parameters according to GOLD criteria were compared using ANOVA. The correlations between CT parameters and PFT indices, including the ratio of forced expiratory volume in one second to forced vital capacity (FEV₁/FVC) and FEV₁, were assessed. To evaluate whether CT parameters can be used to predict PFT indices, multiple linear regression analyses were performed for all patients, Group 1 (GOLD I and II), and Group 2 (GOLD III and IV).
RESULTS: Pulmonary function deteriorated with increase in disease severity according to the GOLD criteria (p < 0.001). Parenchymal attenuation parameters were significantly worse in patients with higher GOLD stages (p < 0.001), and Pi10 was highest for patients with GOLD III (4.41 ± 0.94 mm). Airway parameters were nonlinearly correlated with PFT results, and Pi10 demonstrated mild correlation with FEV₁/FVC in patients with GOLD II and III (r = 0.16, p = 0.06 and r = 0.21, p = 0.04, respectively). Parenchymal attenuation parameters, airway parameters, EI, and Pi10 were identified as predictors of FEV₁/FVC for the entire study sample and for Group 1 (R² = 0.38 and 0.22, respectively; p < 0.001). However, only parenchymal attenuation parameter, EI, was identified as a predictor of FEV₁/FVC for Group 2 (R² = 0.37, p < 0.001). Similar results were obtained for FEV₁.
CONCLUSION: Airway and parenchymal attenuation parameters are independent predictors of pulmonary function in patients with mild COPD, whereas parenchymal attenuation parameters are dominant independent predictors of pulmonary function in patients with severe COPD.
引用
- Koo HJ, Lee SM, Seo JB, et al. Prediction of Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease: Correlation with Quantitative CT Parameters. Korean J Radiol. 2019. PMID: 30887750. doi:10.3348/kjr.2018.0391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。